The risk of mortality among older adults hospitalized with influenza was significantly lower among those who received oseltamivir vs no antiviral therapy.

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

Pain complaints among hospitalized patients with COVID-19 were negatively correlated with emergency intubation.